ARTICLE | Clinical News
CpG 7909: Began Phase I/II trial
April 24, 2000 7:00 AM UTC
Coley Pharmaceutical Group Inc., Wellesley, Mass. Product: CpG 7909 Business: Cancer Therapeutic category: Adjuvant, Immune stimulation Target: Immune cells Description: CpG-containing oligonucleotid...